CMPO vs TMO · rev $420.6M vs P/E 24, rev $44.56B
CompoSecure, Inc. (CMPO) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
CompoSecure, Inc. (CMPO) is a metal fabrication company listed on NYSE.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported CMPO revenue for 2024-12-31 was $420.6M. Net income was -$83.2M. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. CMPO currently screens at market cap $7.28B.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
CMPO currently screens at market cap $7.28B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the CMPO and TMO stock pages for the full models.
Not investment advice.